ABBV
AbbVie Inc.
Stock
$266.28+1.94 (+0.73%)Close Sep 28, 2026
ABBV's operating income for 2025 was $15.08 billion, up 65.0% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 3, 2026
| Operating income (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $16.87B | +53.8% | 5.8% | 7.2% |
| Operating income (TTM) | $16.87B |
|---|---|
| YoY | +53.8% |
| 5-year CAGR | 5.8% |
| 10-year CAGR | 7.2% |
Operating income
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $15.1B | +65.0% |
| 2024 | $9.1B | −28.4% |
| 2023 | $12.8B | −29.6% |
| 2022 | $18.1B | +1.1% |
| 2021 | $17.9B | +57.7% |
| 2020 | $11.4B | −12.5% |
| 2019 | $13.0B | +103.4% |
| 2018 | $6.4B | −33.1% |
| 2017 | $9.5B | +2.2% |
| 2016 | $9.3B | +23.9% |
| 2015 | $7.5B | +121.0% |
| 2014 | $3.4B | −39.8% |
| 2013 | $5.7B | −2.6% |
| 2012 | $5.8B | +60.7% |
| 2011 | $3.6B | — |